Gene therapy in an era of emerging treatment options for hemophilia B von Monahan, P. E.

Volltext

The expanding menagerie: animal models of hemophilia A von MONAHAN, P. E.

Volltext

Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia von Li, C, Narkbunnam, N, Samulski, R J, Asokan, A, Hu, G, Jacobson, L J, Manco-Johnson, M J, Monahan, P E

Volltext

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B von Pipe, S.W, Leebeek, F.W.G, Recht, M, Key, N.S, Castaman, G, Miesbach, W, Lattimore, S, Peerlinck, K, Van der Valk, P, Coppens, M, Kampmann, P, Meijer, K, O'Connell, N, Pasi, K.J, Hart, D.P, Kazmi, R, Astermark, J, Hermans, C.R.J.R, Klamroth, R, Lemons, R, Visweshwar, N, von Drygalski, A, Young, G, Crary, S.E, Escobar, M, Gomez, E, Kruse-Jarres, R, Quon, D.V, Symington, E, Wang, M, Wheeler, A.P, Gut, R, Liu, Y.P, Dolmetsch, R.E, Cooper, D.L, Li, Y, Goldstein, B, Monahan, P.E

Volltext

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study von Antun, A., Monahan, P. E., Manco‐Johnson, M. J., Callaghan, M. U., Kanin, M., Knoll, C., Carpenter, S. L., Davis, J. A., Guerrera, M. F., Kruse‐Jarres, R., Ragni, M. V., Witmer, C., McCracken, C. E., Kempton, C. L.

Volltext

IL‐6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding‐induced arthropathy in hemophilia von Narkbunnam, N., Sun, J., Hu, G., Lin, F.‐C., Bateman, T. A., Mihara, M., Monahan, P. E.

Volltext

Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy von Keravala, A, Chavez, C L, Hu, G, Woodard, L E, Monahan, P E, Calos, M P

Volltext

Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV von GUI, T., REHEMAN, A., NI, H., GROSS, P. L., YIN, F., MONROE, D., MONAHAN, P. E., STAFFORD, D. W.

Volltext

Inhibitor Recurrence Following Immune Tolerance Induction: A Multicenter Retrospective Cohort Study von Antun, A., Monahan, P.E., Manco-Johnson, M.J., Callaghan, M.U., Kanin, M., Knoll, C., Carpenter, S.L., Davis, J.A., Guerrera, M.F., Kruse-Jarres, R., Ragni, M.V., Witmer, C., McCracken, C.E., Kempton, C.L.

Volltext

Neonatal immune tolerance for hemophilia: can we ‘tolerate’ new paradigms for gene therapy trials? von MONAHAN, P. E.

Volltext

FACTOR IX CONCENTRATED IN THE JOINT SPACE PROTECTS HEMOPHILIA B MICE FROM BLEEDING-INDUCED JOINT DETERIORATION IN THE ABSENCE OF CIRCULATING FACTOR IX von Sun, J., Hakobyan, N., Valentino, L.A., Monahan, P.E.

Volltext

Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide von Van Cott, K. E., Monahan, P. E., Nichols, T. C., Velander, W. H.

Volltext

Environmental Quality of Long Island Sound: Assessment and Management Issues von Wolfe, D. A., Monahan, R., Stacey, P. E., Farrow, D. R. G., Robertson, A.

Volltext